refer to the NHS medicines information pages and the MHRA/EMC SmPC for eligibility and safety details [13] Semaglutide (Wegovy) approved by the MHRA and recommended by NICE (Technology Appraisal TA875) for weight management in eligible adults (BMI 35 kg/m with at least one weight-related comorbidity, or BMI 3034
Request an Appointment
CST FILM DESCRIPTION: In the face of fracturing societies, climate change, and the hollowing out of democracy, The New Corporation is a cry for social justice, deeper democracy, and transformative solutions
In elderly patients with T2DM, GLP-1RAs have been shown to have the potential not only to control glycemia, but also to improve cognitive function and gait disorders [35]
A professor of medicine at Northwestern University's Feinberg School of Medicine, he helped lead the clinical trials that brought semaglutide to market, and he spent the decades before that treating obesity with diet, behavior change, and lifestyle coaching